Navigation Links
China Medical Technologies Reports Third Fiscal Quarter Financial Results
Date:3/3/2010

ss="xn-money">US$5.0 million (including transaction costs). The Company will continue to repurchase issued and outstanding ADSs depending on market conditions, the trading price of its ADSs and other factors.

Outlook for 4Q FY2009

Although the New Year holiday in January 2010 and the Chinese New Year holiday in February 2010 reduced about 10% of normal working days in 4Q FY2009, the Company still expects to achieve sequential growth in its business. In 1Q FY2010, without the holiday impact, the Company expects to achieve a higher sequential growth in its business.

The Company estimates the target revenues for 4Q FY2009 to be more than RMB175.0 million (US$25.6 million).

The Company estimates the target non-GAAP income from continuing operations for 4Q FY2009 to be more than RMB47.0 million (US$6.9 million).


'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Calif. , April 1, 2015  ValGenesis Inc., ... solutions, announced today that it has completed its Service ... 101, Attest Engagements (AICPA, Professional Standards) for the period ... st 2014.  ... The SOC ...
(Date:4/1/2015)... Mass. , April 1, 2015  EMD Serono, ... Germany , announced today the appointment of ... Medical Affairs, Neurology and Immunology. In this capacity, he ... and business development projects and collaborations for Rebif ® ... and Neurology pipeline. Dr. Munschauer joins ...
(Date:4/1/2015)... FORT LAUDERDALE, Fla. , April 1, 2015 /PRNewswire/ ... nothing at all about oral cancer (68 percent) and ... at their last dental check-up, according to findings from ... Inc. ("Vigilant"), a leading innovator and developer of ... of cancer. The online survey polled 1,050 ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and Markets ... addition of the "Forensic Technologies and Services ... their offering. This report analyzes the ... US$ Million by the following Segments: Forensic Databases, ... and Others. Annual estimates and forecasts ...
Breaking Biology Technology:ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 2EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 4EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 5National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 2National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 3National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 4Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 2Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 3Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 4Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 5Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 6Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 7
... AMSTERDAM, August 17 SynCo Bio Partners, ... a strategic partnership to produce Versartis, lead drug candidate,VRS-859, ... type 2 diabetes,Under the agreement, SynCo will further develop ... manufacturing process to,increase yields for the forthcoming cGMP production. ...
... , , , ... BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading manufacturer ... today announced that it has entered into a non-exclusive distribution ... STEMCELL Technologies, a member of the StemCell Group of companies, ...
... MD, and Christchurch, NZ June 25, 2009 ... detection solutions, today reported that new independent data to ... the exceptional accuracy of its Ceeker (pronounced "seeker") portable ... similar-looking hoax substances. The data show that in ...
Cached Biology Technology:SynCo Bio Partners to Manufacture Versartis Novel Drug for Type 2 Diabetes 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 3Novel handheld device detects anthrax with outstanding accuracy and reliability 2Novel handheld device detects anthrax with outstanding accuracy and reliability 3
(Date:3/12/2015)... BERLIN , March 12, 2015 ... IAM, a standardized identity and access management (IAM) ... reliable implementation schedule. With Beta System,s new IAM ... and best practices gleaned from multiple IAM implementations ... includes the software as well as any necessary ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
(Date:3/5/2015)... In Brazil , cloud computing ... these solutions and 42 percent planning to invest in them ... percent of the companies will be investing in these solutions ... companies in the region are currently opting for the private ... command significant attention in the coming years. This trend is ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4
... In a first-of-its-kind clinical trial, physician-scientists at University Hospitals ... Western Reserve University School of Medicine are studying a ... five-year study is recruiting patients to compare the effectiveness ... large colon polyps. SDNA is a ...
... geneticist Alexander Varshavsky (California Institute of Technology, USA), who was ... 1977, has been awarded the Otto Warburg Medal of the ... is considered to be the highest German award for biochemists ... carried out with yeast and cell cultures of higher organisms, ...
... addition to being among his most vibrant and celebrated works, ... mutation whose genetic basis has, until now, been a bit ... (March 29) in the journal PLoS Genetics , however, ... behind the distinctive, thick bands of yellow "double flowers" that ...
Cached Biology News:New clinical trial explores novel noninvasive colon cancer screening test 2New clinical trial explores novel noninvasive colon cancer screening test 3Otto Warburg Medal for Alexander Varshavsky 2Otto Warburg Medal for Alexander Varshavsky 3UGA scientists reveal genetic mutation depicted in van Gogh's sunflower paintings 2
Rabbit polyclonal antibody to Glutathione-S-Transferase (GST)...
... Spectrometer, utilizing many of the high-end ... high throughput and excellent productivity, providing ... Like the GCMS-QP2010 Plus, the GCMS-QP2010s ... optimum separation, 20 temperature ramps, and ...
Chicken polyclonal antibody to Glutathione-S-Transfrease (GST)...
... a single-channel sample processing head, an 8-channel ... dispenser all in one compact, affordable product. ... tips, the Precision XS autoclavable and organic ... for transferring larger volumes. Intuitive Precision Power ...
Biology Products: